Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats

Psychiatry Research - Neuroimaging

Volumn 82, Issue 2, 1998, Pages 107-114

  Dahchour, Abdelkader ^a   De Witte, Philippe ^a   Bolo, Nicolas ^b   Nédélec, Jean François ^b   Muzet, Muriel ^b   Durbin, Philippe ^c   MacHer, Jean Paul ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b FORENAP   (France)

^c Lipha   (France)

Author keywords

Acamprosate; Ethanol withdrawal; Glutamate; Microdialysis; Nucleus accumbens

Indexed keywords

4 AMINOBUTYRIC ACID; ACAMPROSATE; ALANINE; ALCOHOL; ARGININE; ASPARTIC ACID; EXCITATORY AMINO ACID; GLUTAMIC ACID; TAURINE;

ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROCHEMICAL DETECTION; EXCITABILITY; HYPERACTIVITY; INHALATIONAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ALANINE; ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; ARGININE; ASPARTIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; TAURINE;

EID: 0032550745     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(98)00016-X     Document Type: Article

References (55)

1. Berton F., Francesconi W., Madamba S.G., Zieglgänsberger W., Siggins G.R. The anti-craving agent acamprosate enhances NMDA-mediated EPSPs in rat nucleus accumbens neurons in vitro. Social Neuroscience Abstracts. 21:1995;2101.
2. Bonhaus D.W., Huxtable R.J. The interaction of taurine and glutamate metabolism in brains of genetically seizure susceptible and seizure resistant rats. Proceedings of the Western Pharmacological Society. 28:1985;103-105.
3. Bureau M.H., Olsen R.W. Taurine acts on subclass of GABAA receptors in mammalian brain in vitro. European Journal of Pharmacology. 207:1991;9-16.
4. Colombo G., Agabio R., Lobina C., Reali R., Melis F., Fadda F., Gessa G.L. Effect of the calcium channel antagonist darodipine on ethanol withdrawal in rats. Alcohol and Alcoholism. 30:1995;125-131.
5. Dahchour A., Durbin Ph., De Witte P. Ethanol and acamprosate increase the extracellular taurine in the nucleus accumbens: a microdialysis study. Alcohol and Alcoholism. 30:1995;483.
6. Davidson M.D., Wilce P., Shanley B.C. Increased sensitivity of the hippocampus in ethanol dependent rats to toxic effect of N-methyl-D-aspartic acid in vivo. Brain Research. 606:1993;5-9.
7. Dolin S., Little H. Are changes in neuronal calcium channels involved in ethanol tolerance? Journal of Pharmacology and Experimental Therapeutics. 250:1989;985-991.
8. Dolin S., Little H., Hudspith M., Pagonis C., Littleton J. Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology. 26:1987;275-279.
9. Donzanti B.A., Yamamoto B.K. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sciences. 43:1988;913-922.
10. Gewiss M., Heibreder C., Opsomer L., Durbin P., De Witte P. Acamprosate and diazepam differentially modulate alcohol-induced behavioral and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol and Alcoholism. 26:1991;129-137.
11. Grant K.A., Valverius P., Hudspith M., Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. European Journal of Pharmacology. 176:1990;289-296.
12. ++ channel modulating drugs. Brain Research. 410:1987;143-146.
13. Gulya P., Grant K.A., Valverius P., Hoffman P.L., Tabakoff B. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Research. 547:1991;129-134.
14. Harris R.A., Hood W.H. Inhibition of synaptosomal calcium uptake by ethanol. Journal of Pharmacology and Experimental Therapeutics. 213:1980;562-568.
15. Hoffman P.L. Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metabolic Brain Disease. 10:1995;73-79.
16. Hoffman P.L., Tabakoff B. The role of the NMDA receptor in ethanol withdrawal. Experientia. 71:1994;61-70.
17. Hunt W.A. Are binge drinkers more at risk of developing brain damage? Alcohol. 10:1993;559-561.
18. Huxtable R.J. Physiological actions of taurine. Physiological Review. 72:1992;101-163.
19. Huxtable R.J. Taurine in the central nervous system and the mammalian action of taurine. Progress in Neurobiology. 32:1989;471-533.
20. Iorio K.R., Tabakoff B., Hoffman P.L. Glutamate induced neurotoxicity is increased in cerebellar granule cells exposed chronically to ethanol. European Journal of Pharmacology. 248:1993;209-212.
21. Kontro P., Korpi E.R., Oja S.S. Taurine interacts with GABAA and GABAB receptors in the brain. Progress in Clinical Biological Research. 351:1990;83-94.
22. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
23. Koppi S., Eberhardt G., Haller R., Konig P. Calcium-channel-blocking agent in the treatment of acute ethanol withdrawal - caroverine versus meprobamate in a randomized double blind study. Neuropsychobiology. 17:1987;49-52.
24. Kurachi M., Yochihara K., Aihara H. Effect of taurine on depolarization induced L-glutamate and other excitatory amino acids in the isolated spinal cord of frog. Japanese Journal of Pharmacology. 33:1983;1247-1254.
25. Ladewig D., Kncht T., Leher P., Fendl A. Acamprosate - a stabilizing factor in long-term withdrawal of alcoholic patient. Therapeutische Umschau. 50:1993;182-188.
26. Le Bouhris B. Alcoolisation du rat par par voie pulmonaire. Comptes Rendus des Séances de la Société de Biologie. 169:1975;898-904.
27. Le Magnen J., Tran G., Durlach J., Martin C. Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by calcium acetyl homotaurinate. Alcohol. 4:1987;97-102.
28. Leslie S.W., Barr E., Chandler J., Farrar R.P. Inhibition of fast- and slow-phase depolarisation-dependent synaptosomal calcium uptake by ethanol. Journal of Pharmacology and Experimental Therapeutics. 225:1983;571-575.
29. Lhuintre J.P., Daoust M., Moore N., Chretien P., Saligaut C., Tran G., Boismare F., Hillemand B. Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet. 1:1985;1014-1016.
30. Li Y.P., Lombardini J.B. Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover. Brain Research. 553:1991;89-96.
31. Liljequist R. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. European Journal of Pharmacology. 192:1991;197-198.
32. Liljequist R. Interaction of taurine and related compounds with GABAergic neurons in the nucleus raphe dorsalis. Pharmacology, Biochemistry and Behavior. 44:1993;107-112.
33. Little H.J., Dolin S.J., Halsey M.J. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sciences. 39:1986;2059-2065.
34. Littleton, J.M., Al Qatari, M., Little, H.J., 1996. The neurobiology of craving: potential mechanisms for acamprosate. In: Soyka, M. (Ed.), Acamprosate in Relapse Prevention of Alcoholism. Springer-Verlag, Berlin, Heidelberg, pp. 27-46.
35. Littleton, J.M., Geryk, R.J., Grieve, S.J., 1987. Experimental Effects of Acamprosate on Free-Choice Drinking of Ethanol Solutions by Rats. Report of the King's College of London.
36. Littleton J.M., Little H.J., Whittington M.A. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal, doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology. 100:1990;387-392.
37. Littleton J. Acamprosate in alcohol dependence: how does it work? Addiction. 90:1995;1179-1188.
38. Lynch M.A., Littleton J.M. Possible association of alcohol tolerance with increased synaptic calcium sensitivity. Nature. 303:1983;175-176.
39. Madamba S.G., Schweitzer P., Zieglgänsberger W., Siggins R. Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcoholism: Clinical and Experimental Research. 20:1996;651-658.
40. Malminen O., Kontro P. Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. Neurochemistry Research. 11:1986;85-94.
41. Marks S.S., Watson D.L., Carpenter C.L., Messing R.O., Greenberg D.A. Comparative effects of chronic exposure to ethanol and calcium channel antagonists on calcium channel antagonist receptors in cultured neural (PC 12) cells. Journal of Neurochemistry. 53:1989;168-172.
42. Messing R.O., Carpenter C.L., Diamond I., Greenberg D.A. Ethanol regulates calcium channels in clonal neural cells. Proceedings of the National Academy of Sciences USA. 83:1986;6213-6215.
43. North, R.A., 1992. Cellular actions of opiates and cocaine. In: Kalivas, P.W., Samson, H.H. (Eds.), The Neurobiology of Drug and Alcohol Addiction. The New York Academy of Sciences, New York, pp. 1-6.
44. nd Edit.
45. Robinson T.E., Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Research. 450:1988;209-224.
46. Rossetti Z.L., Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. European Journal of Pharmacology. 283:1995;177-183.
47. Ruhe C.A.M., Littleton J.M. The possible role of voltage operated calcium channels in the enhancement of excitatory amino acid toxicity following chronic ethanol exposure in vitro. Alcohol and Alcoholism. Suppl. 2:1994;217-221.
48. Shibata S., Shindou T., Tominaga K., Watanabe S. Calcium channel blockers improve hypoxia/hypoglycemia-induced impairment of rat hippocampal 2-deoxyglucose uptake in vitro after ethanol withdrawal. Brain Research. 673:1995;320-324.
49. ++ uptake in synaptosomes and in PC 12 cells. Biochemical Pharmacology. 36:1987;2227-2229.
50. Tran G., Steru L., Daoust M., Parot P., Ladure P., Libert C., Boismare F. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and Alcoholism. 25:1990;613-622.
51. Whittington M.A., Butterworth A.R., Dolin S.J., Patch T.L., Little H.J. The effects of chronic treatment with the dihydropyridine, Bay K 8644, on hyperexcitability due to ethanol withdrawal, in vivo and in vitro. British Journal of Pharmacology. 105:1992;285-292.
52. Whittington M.A., Dolin S.J., Patch T.L., Slarey R.J., Butterworth A.R., Little H.J. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to chronic ethanol treatment. British Journal of Pharmacology. 103:1991;1669-1676.
53. Whittington M.A., Lambert J.D., Little H.J. Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyper excitability. Alcohol and Alcoholism. 30:1995;105-114.
54. Williams M., Risley E.A., Totaro J.A. Interaction of taurine and bet-alanine with central nervous system neurotransmitter receptors. Life Sciences. 26:1980;557.
55. Zeise M.L., Kasparow S., Capogna M., Zieglgänsberger W. Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of axcitatory amino acids receptors. European Journal of Pharmacology. 231:1993;47-52.